We are live on ! Find out more
ARRY

Array Biopharma Inc
ARRY

Delisted

ARRY was delisted on the 29th of July, 2019.

Back to rankings

169 hedge funds and large institutions have $1B invested in Array Biopharma Inc in 2016 Q3 according to their latest regulatory filings, with 56 funds opening new positions, 46 increasing their positions, 40 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 56 | Existing positions closed: 14

125% more capital invested

Capital invested by funds: $445M → $1B (+$556M)

67% more funds holding in top 10

Funds holding in top 10: 3 → 5 (+2)

32% more funds holding

Funds holding: 128 → 169 (+41)

15% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 40

24% less call options, than puts

Call options by funds: $8.53M | Put options by funds: $11.2M

Holders
169
Holders Change
+41
Holders Change %
+32.03%
% of All Funds
4.51%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.13%
New
56
Increased
46
Reduced
40
Closed
14
Calls
$8.53M
Puts
$11.2M
Net Calls
-$2.65M
Net Calls Change
-$3.35M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$43.9M
2
Franklin Resources
Franklin Resources
California
+$16.8M
3
Millennium Management
Millennium Management
New York
+$14.1M
4
O
OrbiMed
New York
+$12.4M
5
Invesco
Invesco
Georgia
+$7.45M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$26M
2
RG
Redmile Group
California
-$9.64M
3
BI
BVF Inc
California
-$6.96M
4
BBA
Baker Bros. Advisors
New York
-$3.87M
5
Citadel Advisors
Citadel Advisors
Florida
-$3.33M
Name Holding Trade Value Shares
Change 		Change in
Stake
PI
76
Putnam Investments
Massachusetts
$910K +$522K +134,841 New
New York State Common Retirement Fund
77
New York State Common Retirement Fund
New York
$900K – – –
Handelsbanken Fonder
78
Handelsbanken Fonder
Sweden
$878K +$503K +130,000 New
NFA
79
Nationwide Fund Advisors
Ohio
$863K +$142K +36,661 +40%
ACM
80
Atika Capital Management
New York
$857K +$491K +127,000 New
Nisa Investment Advisors
81
Nisa Investment Advisors
Missouri
$842K +$249K +64,500 +107%
EA
82
Emerald Acquisition
Washington
$834K +$478K +123,502 New
SSA
83
Schonfeld Strategic Advisors
New York
$819K +$469K +121,309 New
ProShare Advisors
84
ProShare Advisors
Maryland
$713K -$72.7K -18,794 -15%
Manulife (Manufacturers Life Insurance)
85
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$690K +$143 +37 +0%
TAM
86
Tocqueville Asset Management
New York
$675K – – –
Janus Henderson Group
87
Janus Henderson Group
United Kingdom
$675K +$387K +100,000 New
MLICM
88
Metropolitan Life Insurance Company (MetLife)
New York
$666K +$2.05K +531 +0.5%
State Board of Administration of Florida Retirement System
89
State Board of Administration of Florida Retirement System
Florida
$575K – – –
AIG
90
American International Group
New York
$562K +$491 +127 +0.2%
UBS AM
91
UBS AM
Illinois
$555K – – –
GCP
92
GSA Capital Partners
United Kingdom
$547K +$314K +81,085 New
VEA
93
Virtus ETF Advisers
New York
$507K – – –
HCMT
94
Highland Capital Management (Texas)
Texas
$506K +$290K +75,000 New
BA
95
BlackRock Advisors
Delaware
$498K +$17.1K +4,421 +6%
PPA
96
Parametric Portfolio Associates
Washington
$472K -$35.8K -9,254 -12%
GL
97
GLG LLC
New York
$470K +$269K +69,649 New
GP
98
GLG Partners
United Kingdom
$470K +$269K +69,651 New
DCM
99
DAFNA Capital Management
California
$468K +$268K +69,300 New
VFA
100
Virtus Fund Advisers
Connecticut
$453K – – –
2 3
4
5 6

ARRY Hedge Fund Activity: Q3 2016 in Review

169 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Array Biopharma Inc (ARRY) for Q3 2016, worth a combined $1B — up 125% from $445M a quarter earlier.

Buyers outnumbered sellers: 56 funds opened new ARRY positions and 14 closed out — a net gain of 42 holders — while 46 added to existing stakes and 40 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $43.9M. The largest seller was Deerfield Management, cutting an estimated $26M.

  • 169 institutional investors held Array Biopharma Inc (ARRY) as of Q3 2016, up from 128 in Q2 2016.
  • Funds reported $1B of Array Biopharma Inc stock for Q3 2016, up 125% quarter-over-quarter.
  • 56 funds opened new Array Biopharma Inc positions in Q3 2016 and 14 closed out, a net change of +42 holders.
  • The largest Array Biopharma Inc buyer in Q3 2016 was Fidelity Investments, an estimated $43.9M added.
  • The largest Array Biopharma Inc seller in Q3 2016 was Deerfield Management, an estimated $26M sold.

Based on aggregated 13F filings for Q3 2016.